| Literature DB >> 26523291 |
Kamnesh Pradhan1, Julie Mund2, Jamie Case3, Samir Gupta4, Ziyue Liu5, Wambui Gathirua-Mwangi6, Anna McDaniel7, Jamie Renbarger1, Victoria Champion8.
Abstract
Radiation during childhood cancer treatment increases the propensity to atherosclerotic cardiovascular disease among adult survivors of childhood cancer. This is thought to be mediated through the damage to the underlying vascular endothelium. Endothelial progenitor cells (EPCs) involved in vascular endothelial repair after its damage may be affected by radiation therapy but have never been investigated in adult survivors of childhood cancer. In this pilot study, utilizing multi-parametric flowcytometry, endothelial colony forming cells (ECFCs), which are the bonafide EPCs, and circulating endothelial cells (CECs), which are not EPCs, were compared between adult survivors of childhood cancer with or without radiation exposure. In addition, their associations with blood-pressure, physical activity and diet were examined. Survivors who received radiotherapy had lower ECFCs and CECs (p<0.05) compared to those without it. Significant positive correlations included physical activity with ECFCs and diet with CECs, while blood-pressure negatively correlated with ECFCs. Further evaluation is needed to examine the effect of radiation and modifiable risk factors on ECFCs and CECs. The preliminary findings from this study suggest evidence of the role of ECFCs as biomarkers of vascular injury following treatment for childhood cancer that may help in early identification of survivors at risk for cardiovascular disease.Entities:
Keywords: Childhood cancer survivors; Endothelial cell functions; Long-term toxicities; Pediatric cancers; Radiation induced late effects
Year: 2015 PMID: 26523291 PMCID: PMC4627707 DOI: 10.13188/2380-6842.1000005
Source DB: PubMed Journal: J Hematol Thromb ISSN: 2380-6842
Figure 1Representative gating strategy of ECFC and CEC populations using Flow Cytometry. Following exclusion of dead cells, low side scatter mononuclear cells were plotted to show CD34 and CD45 (Radiation (XRT): A, Non-XRT: D). CD45−CD34+ cells were gated [red] and subsequently gated for CD31 to verify endothelial phenotype (XRT: B; Non-XRT: E). CD45−CD34dim cells were gated [green] and subsequently gated for CD31 to verify endothelial phenotype (XRT: C; Non-XRT: F).
Treatment groups of all survivors.
| Treatment Groups | Acute Leukemia (n=17) | Solid Tumors (n=7) | Total |
|---|---|---|---|
| With XRT | 8 | 7 | 15 |
| Without XRT | 9 | -- | 9 |
| Cisplatin | -- | -- | 0 |
| Anthracyclines | 9 | 0 | 9 |
| Cisplatin + XRT | -- | 6 | 6 |
| Anthracyclines + XRT | 8 | 1 | 9 |
| SCT | 3 | -- | 3 |
XRT: Radiation Therapy; SCT: Stem Cell Transplantation
Figure 2Box-plots showing levels of circulating endothelial cells (CECs) and endothelial colony forming cells (ECFCs) among childhood cancer survivors treated with and without Radiation (XRT).
Clinical data of the survivors who received Radiotherapy.
| Primary diagnosis | Field of XRT | XRT dose (Gy) | Time-Interval between XRT and Study Visit (years) |
|---|---|---|---|
| B-ALL with testicular relapse | Bilateral Testicles | 21 | 8 |
| B-ALL with CNS+ | Cranial | 18 | 16 |
| B-ALL relapse | CSI + Cranial boost | 18 + 6 | 10 |
| APML with CNS+ | CSI | 21.6 | 5 |
| B-ALL with relapse | CSI + Cranial boost + TBI | 18 + 6 + 13.5 | 10 |
| Ph+ ALL | TBI + Cranial boost | 12 + 6 | 7 |
| B-ALL with CNS+ | Cranial | 18 | 10 |
| B-ALL with CNS+ | CSI | 18 + 6 | 13 |
| Medulloblastoma | CSI + PF boost | 23.4 + 55.4 | 8 |
| Medulloblastoma | CSI + PF boost | 23.4 + 55.4 | 9 |
| CNS/PNET | CSI + tumor bed boost | 36 + 50.4 | 6 |
| Medulloblastoma | CSI + PF boost | 36 + 50.5 | 7 |
| Pineoblastoma | CSI + tumor bed boost | 36 + 50.4 | 7 |
| Medulloblastoma | CSI + PF boost | 23.4 + 55.4 | 13 |
| Ewing’s Sarcoma | Focal (Left Parietal Skull) | 45-54 | 16 |
XRT: Radiation Therapy; B-ALL: Precursor-B Acute Lymphoblastic Leukemia; CNS+: Central Nervous System is positive for leukemic infiltration; APML: Acute Promyelocytic Leukemia; Ph+ ALL: Philadelphia chromosome ALL; CNS/PNET: Peripheral Neuro-ectodermal Tumor of the Brain; CSI: Cranio-Spinal; boost: Additional XRT; PF: Posterior fossa of the Brain; TBI: Total Body Irradiation; Focal: tumor and surrounding margin only; Gy: Gray (unit of radiation dose)